Dr. Luigina Guasti, University of Insubria, Head, Internal Medicine 1 Unit, Varese, Italy
Dr. Peng Miao, Chinese Academy of Sciences, Suzhou Institute of Biomedical Engineering and Technology, China
Dr. Chaoqun Zhang, South China Agricultural University, China
Submit manuscript at www.itmedicalteam.pl/submissions/translational-biomedicine.html or send as an e-mail attachment to the Editorial Office at [email protected]
Aim and Scope
Translational Biomedicine is an international open access*, peer-reviewed academic journal with Journal Impact Factor 1.12. The Journal publishes original science-based research that advances communication between the scientific discovery and health improvement.
The journal covers the advancement intranslational medicine,molecular medicine, translational genomics,clinical genetics, Translational research & clinical intervention, Translational stroke, Translational Neuroscience, Translational Oncology, Cardiovascular science, Stem cellTranslational Medicineetc.
Translational Biomedicine is indexed and abstracted in the following databases:
Scimago, CiteFactor, SciLit, DeepDyve, Genamics JournalSeek, CrossRef, Journal TOC, Open J-Gate, Electronic Journals Library and many more.
Translational Biomedicine publishes original research or commentary on diseases with implications for treatment, where scientific ideas are translated into clinic trials or applications. Commentary on policy, regulation, education, legal and other issues, national or global medical bioinformation.
Translational Biomedicine welcomes research articles, case reports, comprehensive/mini reviews and short communications from basic sciences to clinical sciences.
Articles published in Translational Biomedicine have been cited by esteemed scholars and scientists all around the world. Translational Biomedicine has got h-index 12 , which means every article in Translational Biomedicine has got 12 average citations.
Madhan K* and Manikumar
The effects of cannabinoids are mediated by G-protein coupled cannabinoid receptors 1 (CB1) and 2 (CB2). CB1 is mainly present in the vascular and central nervous system whilst CB2 receptors are found within the immune tissues that are involved in immunomodulation. There is emerging evidence to suggest that the endocannabinoid system plays an important role in regulating the cardiovascular system. This review focuses on the therapeutic potential of Cannabidiol (CBD) on the cardiovascular system.
Anchana P Belmon* and Jeraldin Auxillia
Mohamed Ali Gliti1,3*, Najoua Belhaj2,3, Sophia Nitassi2,3, Bencheikh Razika2,3, Mohamed Anas Benbouzid2,3, Abdelilah Oujilal2,3 and Leila Essakalli Houssyni2,3
Vikas Kumar Maurya